Daily funding roundup - July 17, 2015
Protagonist Therapeutics bagged $40M; Upstart raised $35M; Courtagen secured $20M
- CredSimple, a startup building a medical credentialing database, snagged $1.5 million in seed funding to help healthcare and insurance companies manage their doctor networks. Bowery Capital led the round, with participation from Primary Venture Partners and a handful of angels.
- ShoCard raised $1.5 million from Morado Ventures Partners, AME Cloud Ventures, Enspire Capital and Digital Currency Group. ShoCard certifies and stores ID documents into the Blockchain, so that you can securely retrieve them later and prove your identity whenever you need to. Its first use case is for bank and credit card identification processes.
- Privitar, a new British tech firm looking to transform the way organisations use sensitive personal or private information, has closed a $1million seed funding round. Privitar attracted over $1million of seed financing in an oversubscribed funding round from investors including: Tom Glocer and Sir Peter Job (both former chief executives of Reuters), Rockspring CEO David Gammon and David Cleevely, founder of Abcam, Cambridge Angels and the Centre for Science and Policy in Cambridge, and co-founder, Gerard Buggy who is CTO of First Derivatives.
- Mumbai-based startup LivQuik, the parent company of mobile payment service QuikWallet, raised $1.6 million in a fresh round of funding from its existing investor Snow Leopard Ventures. The startup will use the freshly raised funds in scaling the team, technology, and merchant base. QuikWallet is a mobile wallet service that lets you pay the bill from your cellphone – no cash or card needed. The startup touted as India’s first mobile app for restaurant and retail payments.
- New York City-based food media company Spoon University raised $2 million in seed funding. The round was led by SoftTech VC with participation from Lerer Hippeau Ventures, Box Group, VaynerRSE, BBG Ventures, MATH fund, Joanne Wilson, Howard Morgan, Project Mayhem Ventures, Kosinski Ventures and RuggedVC. In conjunction with the funding, Stephanie Palmeri of SoftTech VC will join the board.
- Angiodroid, a San Lazzaro di Savena (Bologna), Italy-based medical technology startup, landed $1.6 million in funding. Backers included Innogest, ZernikeMeta Ventures – via Ingenium Emilia-Romagna, and members of Italian Angels for Growth. The company intends to use the funds to increase sales efforts and to introduce new products in its sector of focus.
- InnaVirVax, a biopharmaceutical company specialized in research and development of therapeutic solutions for infectious and major chronic diseases, completed its third funding round which secured $4 Million from its historical investors. The FCPR CapDecisif 2, G1J Ile-de-France, Pradeyrol Development, Fa Dièse and FRCI (Fonds Régional de Co-Investissement d’Ile-de-France) funds have decided to reinforce their support for, and confidence in, the company.
- Workspot, a cloud-based provider of mobile workspace solutions, raised $5 million from a network of investors. The funding is led by Helion Ventures along with Translink Capital and Qualcomm Inc., through its venture investment group, Qualcomm Ventures. The funding will be used to advance Workspot’s powerful technology even more and expand their marketing initiatives.
- Guidebook which gives any organization the ability to easily create and manage native iOS and Android apps for venues and events nabbed $10 million to date in seed and Series A funding. London-based Mosaic Ventures co-led the financing with MHS Capital. With the help of their investors, Guidebook plans to continue its rapid growth in Europe. As part of the Series A financing, Toby Coppel, one of Mosaic's founding partners, has joined Guidebook’s board of directors.
- Massachusetts startup Courtagen roped in $20 million to support development of its genetic tests for pediatric neurology disorders. Existing investors such as Harbor Light Capital and Adler & Co. contributed financing, and new investors including Bunker Hill Capital and First Analysis also participated in the round. The company added two board members as part of the financing, appointing Bain & Co. partner Chuck Farkas as a board member and First Analysis managing director Tracy Marshbanks as a board observer.
- Chinese cooking community Xiachufang raised a $30 million series B funding, its first since the company’s 2012 series A. The new round was led by China Growth Capital, with ecommerce giant JD.com and previous investors Ceyuan Ventures and Zhixin Capital also investing.
- Online lending platform Upstart raised $35 million in Series C funding to expand its services. Third Point Ventures led the round with participation from existing investors such as Khosla Ventures, First Round Capital and Collaborative Fund. The company has raised $42.7 million to date.
- Bay Area startup Protagonist Therapeutics bagged a $40 million Series C to advance its oral, peptide-based gastrointestinal drugs – taking a precision medicine approach to ultimately go up against the top-selling “mabs.” The new funding round was led by new investor Canaan Partners, along with Adage Capital Management, RA Capital Management and Foresite Capital. All the company’s other investors – Johnson & Johnson Innovation, Lilly Ventures, Pharmstandard International and Starfish Ventures – joined the new round as well.
If you are interested in being included in our funding roundup, submit your press release or blog post about your financing round to mitos@vator.tv.
Image source: authoritypublishing.com
Mitos Suson
I produce Vator Events and enjoy the challenge. I am learning and growing a lot, being involved with Vator and loving every moment of it!
All author postsRelated Companies, Investors, and Entrepreneurs
Khosla Ventures
Angel group/VC
Joined Vator on
Khosla Ventures offers venture assistance, strategic advice and capital to entrepreneurs. The firm helps entrepreneurs extend the potential of their ideas in both traditional venture areas like the Internet, computing, mobile, and silicon technology arenas but also supports breakthrough scientific work in clean technology areas such as bio-refineries for energy and bioplastics, solar, battery and other environmentally friendly technologies. Vinod was formerly a General Partner at Kleiner Perkins and founder of Sun Microsystems. Vinod has been labeled the #1 VC by Forbes and Fortune recently labeled him as one the nation's most influential ethanol advocates, noting "there are venture capitalists, and there's Vinod Khosla." Vinod Khosla founded the firm in 2004.
SofttechVC
Angel group/VC
Joined Vator on
SoftTech VC is one of the original micro VC firms, founded in 2004 and backing over 135 early-stage start-ups. Based in Palo Alto, the firm manages two institutionally-backed funds and invests in Silicon Valley, New York, Southern California, Boulder and Canada. SoftTech VC is among the most active investors in early stage consumer Internet and B2B startups, consistently investing in 20 new opportunities a year. We seek great entrepreneurs, differentiated products and large market opportunities. More information available at www.softtechvc.com.
Founder and managing partner Jeff Clavier launched SoftTech VC in 2004, making the original 20+ investments (our non-traditional ‘Fund I’) as a business angel, investing his own capital, time and experience. As one of the original ‘super angels’ in the valley, Jeff developed SoftTech VC’s implementation of the micro-vc concept which has become so popular.
Bowery Capital
Angel group/VC
Joined Vator on
“Bowery Capital is an early-stage venture capital fund investing in business software. Bowery Capital is focused on helping its founders build the next generation of B2B market leaders.” And for a longer version: “Bowery Capital focuses exclusively on supporting startups that disrupt and upgrade legacy marketing and IT products and services across all organizations. As more and more internet natives drive purchasing decisions, Bowery Capital believes that roughly $357B will change hands over the next 10 years as old products are replaced with new. The firm believes that the key ingredient to early success is MRR and ARR growth, and as such provides various sales tools that portfolio companies can leverage to develop a strong early customer base. This combination of a focused thesis and value-added support are the cornerstones of Bowery Capital's investment approach.